# VESIcare For Improving OAB Symptoms in Patients Undergoing IGRT of the Prostate

> **NCT01777217** · PHASE4 · TERMINATED · sponsor: **Advanced Research Network** · enrollment: 8 (actual)

## Conditions studied

- Over-Active Bladder

## Interventions

- **DRUG:** Solifenacin succinate
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01777217
- **Lead sponsor:** Advanced Research Network
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-02
- **Primary completion:** 2014-01
- **Final completion:** 2014-01
- **Target enrollment:** 8 (ACTUAL)
- **Why stopped:** Terminated
- **Last updated:** 2015-01-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01777217

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01777217, "VESIcare For Improving OAB Symptoms in Patients Undergoing IGRT of the Prostate". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01777217. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*